Based on these results, single cell analysis revealed a remarkably higher TGFBI expression in TAMs or even cycling TAMs, so we presume that TGFBI can not only directly affect cancer cells, but also promote disease progression through TAMs, which proves its value as therapeutic targets. Here, TGFBI is linked to cancer.